RT Journal Article
SR Electronic
T1 Ligufalimab, a novel anti-CD47 antibody with no hemagglutination demonstrates both monotherapy and combo antitumor activity
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005517
DO 10.1136/jitc-2022-005517
VO 10
IS 11
A1 Qu, Tailong
A1 Zhong, Tingting
A1 Pang, Xinghua
A1 Huang, Zhaoliang
A1 Jin, Chunshan
A1 Wang, Zhongmin Maxwell
A1 Li, Baiyong
A1 Xia, Yu
YR 2022
UL http://jitc.bmj.com/content/10/11/e005517.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.